Form 4 for FDMT 4D Molecular Therapeutics, Inc.
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0000950170-24-041418 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-04-03 | 2024-04-01 | FDMT | Bizily Scott | CLO | M - OptEx | $12.54 | +8,153 | 7,981 | New | +$102.2K |
| DT | 2024-04-03 | 2024-04-01 | FDMT | Bizily Scott | CLO | S - Sale+OE | $31.78 | -8,153 | 1,737 | -82% | -$259.1K |
| DMT | 2024-04-03 | 2024-04-01 | FDMT | Bizily Scott | CLO | M - OptEx | $0.00 | -8,153 | 46.2K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-01 | M | A | 2,916 | $8.04 | 5,985 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-01 | M | A | 1,909 | $20.24 | 9,890 | D | — | — | |
| 3 | Common | Common Stock | 2024-04-01 | M | A | 1,332 | $6.49 | 3,069 | D | — | — | |
| 4 | Common | Common Stock | 2024-04-01 | S | D | 8,153 | $31.78 | 1,737 | D | — | — | |
| 5 | Common | Common Stock | 2024-04-01 | M | A | 1,996 | $15.78 | 7,981 | D | — | — | |
| 6 | Derivative | Stock Option (Right To Buy) | 2024-04-01 | M | D | 1,332 | $0.00 | 14,711 | D | $6.49 · — to 2032-06-17 | 1,332 Common Stock | (F2) The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of June 16, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. |
| 7 | Derivative | Stock Option (Right To Buy) | 2024-04-01 | M | D | 1,996 | $0.00 | 21,008 | D | $15.78 · — to 2032-01-31 | 1,996 Common Stock | (F4) The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. |
| 8 | Derivative | Stock Option (Right To Buy) | 2024-04-01 | M | D | 2,916 | $0.00 | 40,418 | D | $8.04 · — to 2032-08-31 | 2,916 Common Stock | (F3) The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. |
| 9 | Derivative | Stock Option (Right To Buy) | 2024-04-01 | M | D | 1,909 | $0.00 | 46,182 | D | $20.24 · — to 2033-02-09 | 1,909 Common Stock | (F5) The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 10, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. |